Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves’ Disease: A Nationwide Population-Based Cohort Study

BACKGROUND: Optimal treatment for persistent Graves’ disease following 12–18 months of treatment with anti-thyroid drugs (ATDs) is unclear. Given the increased risk of cardiovascular morbidity and mortality with hyperthyroidism, assessing the risk of cardiovascular events associated with different t...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Eyun, Kim, Mina, Park, Sojeong, Park, Min Jeong, Kim, Jung A., Roh, Eun, Yu, Ji Hee, Kim, Nam Hoon, Seo, Ji A., Kim, Sin Gon, Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Yoo, Hye Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531545/
https://www.ncbi.nlm.nih.gov/pubmed/34690936
http://dx.doi.org/10.3389/fendo.2021.761782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531545/
https://www.ncbi.nlm.nih.gov/pubmed/34690936
http://dx.doi.org/10.3389/fendo.2021.761782

Ejemplares similares